The 510(k) clearance allows for modification of the labeling of the previously authorized pharmacogenetics report. The Food and Drug Administration (FDA) has granted 23andMe clearance for its CYP2C19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results